Pacemaker Requirement Index after TAVR Calculator

Clinical calculation support · Verify results before clinical use

Patient and procedural predictors

Enter the variables reported in the Qi et al. post-procedural model. This page currently summarizes predictors; it does not generate an unverified probability.

Clinical
decision support

RBBB present before TAVR.

Enter the measured pre-TAVR AVA.

Post-procedural AVA divided by pre-procedural AVA; enter the ratio, not a percentage.

Clinical context

The 2023 Qi et al. study developed a post-procedural model for permanent pacemaker implantation after TAVR. The reported independent predictors included pre-existing RBBB, pre-procedural AVA, and the ratio of post- to pre-procedural AVA. The model was derived in a single-centre cohort and externally validated; reported discrimination was modest (AUC 0.70 in derivation and 0.71 in external validation).

How to use this page

  • Enter all three variables to review the recorded predictor profile.
  • Do not interpret this page as an individual probability, validated risk score, or a replacement for ECG/conduction monitoring and clinical assessment.
  • For a deployable numeric score, verify the published point conversion, score thresholds, and original validation materials before implementation.

Reference

Qi Y, Lin X, Pan W, et al.

A prediction model for permanent pacemaker implantation after transcatheter aortic valve replacement. European Journal of Medical Research. 2023;28:262.

doi:10.1186/s40001-023-01237-w

PubMed PMID: 37516891

Clinical disclaimer: This tool provides a predictor summary only and does not calculate a validated probability of permanent pacemaker implantation. The published model was developed in a specific study population; performance and calibration may differ in other populations. Use current institutional TAVR conduction-management protocols and clinical judgement.